Crystalline forms of (2R,5S,13AR)-8-hydroxy-7,9,-dioxo-N-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide | Patent Number 09682084
US 09682084 B2Filled DateJun 19, 2015
Priority DateJun 20, 2014
Publication DateDec 24, 2015
Expiration DateJun 19, 2034
Inventor/ApplicantsErnest A. Carra
Katie Ann Keaton
Vahid Zia
Irene Chen
Scott E. Lazerwith
Katie Ann Keaton
Vahid Zia
Irene Chen
Scott E. Lazerwith
ExaminesHABTE, KAHSAY
Art Unit1624
Technology Center1600
Law Firm
You must be logged in to view
LoginAttorneys
Subscription-Only
View Concierge Program
Empower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.